American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Getting to the Heart of Cannabis Health Risks

Lead Story: Getting to the Heart of Cannabis Health Risks

Tuesday 31st May 2022

Explore cannabis' cardiovascular risks and more in ASAM's addiction medicine podcast. Learn about genistein's potential benefits and other key addiction topics.
6 minutes
Informative
Educational
Thought-provoking
Engaging
Supportive

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Cannabis and Heart Health: Key Findings from ASAM's Addiction Medicine Podcast

The study finds that inflammatory markers in the body increase after use of a single marijuana joint. The study also finds links between THC-induced vascular inflammation, endothelial dysfunction, cellular oxidative stress, and atherosclerosis.
Have you ever wondered about the impact of cannabis on your heart? This episode of 'This Week in Addiction Medicine' from ASAM dives deep into the cardiovascular risks associated with marijuana use. Host Claire Rasmussen unpacks a groundbreaking study from Cell Press that shows how just one marijuana joint can spike inflammatory markers and trigger vascular inflammation, endothelial dysfunction, oxidative stress, and even atherosclerosis. But there's a twist—genistein, a compound found in soy, might help mitigate these harmful effects.
It's not all about cannabis, though. Rasmussen also explores a fascinating trial comparing e-cigarettes and nicotine patches for pregnant smokers trying to quit. You'll get insights into the effectiveness of each method and the unexpected findings when participants mixed both approaches. The episode doesn't stop there. It covers a wide range of topics, from the patterns of cannabis use among U.S. adults to the latest on treating major depressive disorder with AXS.
There's also a poignant look at mental health and substance use among homeless adolescents, emphasizing the urgent need for federal support for overdose prevention centers. If you're grappling with benzodiazepine dependence or curious about patient-centered measures of success in opioid use disorder treatment, this episode has something for you too. Whether you're a healthcare professional, a researcher, or someone personally affected by addiction, this podcast offers a wealth of knowledge and real-world applications.
Tune in for an episode that's both informative and eye-opening.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.